Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Samuel Ignacio Pascual‐Pascual"'
Autor:
Candela Machuca, Angel Vilches, Eleonora Clemente, Samuel Ignacio Pascual-Pascual, Arantxa Bolinches-Amorós, Ana Artero Castro, Carmen Espinos, Marian Leon, Pavla Jendelova, Slaven Erceg
Publikováno v:
Stem Cell Research, Vol 33, Iss , Pp 166-170 (2018)
The human iPSC cell line, CARS-FiPS4F1 (ESi064-A), derived from dermal fibroblast from the apparently healthy carrier of the mutation of the gene SACSIN, was generated by non-integrative reprogramming technology using OCT3/4, SOX2, CMYC and KLF4 repr
Externí odkaz:
https://doaj.org/article/6099d90be0f440dab9874731f3220b0f
Autor:
Candela Machuca Arellano, Angel Vilches, Eleonora Clemente, Samuel Ignacio Pascual-Pascual, Arantxa Bolinches-Amorós, Ana Artero Castro, Carmen Espinos, Marian Leon Rodriguez, Pavla Jendelova, Slaven Erceg
Publikováno v:
Stem Cell Research, Vol 31, Iss , Pp 249-252 (2018)
The human iPSC cell line, ARS-FiPS4F1 (ESi063-A), derived from dermal fibroblast from the patient autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutations on the gene SACSIN, was generated by non-integrative reprogrammin
Externí odkaz:
https://doaj.org/article/0e4c7322f2a443f193c4de107a9fca4b
Autor:
Ana Méndez-Echevarría, María Belén Caminoa, Teresa del Rosal, Inmaculada Casas, Francisco Pozo, Samuel Ignacio Pascual-Pascual, Mar García-Romero, Carmen Cámara, Cristina Calvo
Publikováno v:
Viruses, Vol 13, Iss 5, p 867 (2021)
Background: The impact of respiratory virus infection in patients diagnosed with ataxia-telangiectasia (A-T) has not been well studied. Methods: A prospective case control study was performed at a National Reference Unit for Primary Immunodeficiency
Externí odkaz:
https://doaj.org/article/1506ee36f2354af29fd67e0fbfd08c14
Autor:
Gloria Tapias, Mar García-Romero, Carlos Crespo, Maribel Cuesta, Carles Forné, Samuel Ignacio Pascual-Pascual
Publikováno v:
Farmacia Hospitalaria, Vol 40, Iss 5, Pp 412-426 (2016)
Objective: Cost-minimization analysis of onabotulinumtoxinA and abobotulinumtoxinA, taking into account the real dose administered to children with spasticity associated with dynamic equinus foot deformity due to cerebral palsy. Method: A single cent
Externí odkaz:
https://doaj.org/article/67ef647875d8414788beadb40524bdb2
Autor:
Irene Pulido-Valdeolivas, David Gómez-Andrés, Juan Andrés Martín-Gonzalo, Irene Rodríguez-Andonaegui, Javier López-López, Samuel Ignacio Pascual-Pascual, Estrella Rausell
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0192345 (2018)
The Hereditary Spastic Paraplegias (HSP) are a group of heterogeneous disorders with a wide spectrum of underlying neural pathology, and hence HSP patients express a variety of gait abnormalities. Classification of these phenotypes may help in monito
Externí odkaz:
https://doaj.org/article/ca2c1267bd714f989a1a792a8015683b
Autor:
Massimiliano Zanin, David Gómez-Andrés, Irene Pulido-Valdeolivas, Juan Andrés Martín-Gonzalo, Javier López-López, Samuel Ignacio Pascual-Pascual, Estrella Rausell
Publikováno v:
Entropy, Vol 20, Iss 1, p 77 (2018)
Cerebral palsy is a physical impairment stemming from a brain lesion at perinatal time, most of the time resulting in gait abnormalities: the first cause of severe disability in childhood. Gait study, and instrumental gait analysis in particular, has
Externí odkaz:
https://doaj.org/article/d70f9b04bcb74920a1e789ae23770b13
Autor:
Jonàs Juan-Mateu, Lidia González-Quereda, Maria José Rodríguez, Edgard Verdura, Kira Lázaro, Cristina Jou, Andrés Nascimento, Cecilia Jiménez-Mallebrera, Jaume Colomer, Soledad Monges, Fabiana Lubieniecki, Maria Eugenia Foncuberta, Samuel Ignacio Pascual-Pascual, Jesús Molano, Montserrat Baiget, Pia Gallano
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59916 (2013)
DMD nonsense and frameshift mutations lead to severe Duchenne muscular dystrophy while in-frame mutations lead to milder Becker muscular dystrophy. Exceptions are found in 10% of cases and the production of alternatively spliced transcripts is consid
Externí odkaz:
https://doaj.org/article/01f25a8e27ed4e2ab08cfcd4aa96e734
Autor:
Juan F. Vázquez‐Costa, Mercedes Martínez‐Moreno, Marcos Madruga‐Garrido, Francina Munell, Andrés Nascimento, Inmaculada Pitarch‐Castellano, Samuel Ignacio Pascual‐Pascual, Mónica Povedano, Maria Grazia Cattinari
Publikováno v:
European journal of neurologyREFERENCES. 29(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af6b292d6b6736a3be5dde6a791eaa5
https://pubmed.ncbi.nlm.nih.gov/35971869
https://pubmed.ncbi.nlm.nih.gov/35971869
Autor:
Richard S. Finkel, Monique M. Ryan, Samuel Ignacio Pascual Pascual, John W. Day, Eugenio Mercuri, Darryl C. De Vivo, Richard Foster, Jacqueline Montes, Juliana Gurgel‐Giannetti, Drew MacCannell, Zdenek Berger
Publikováno v:
Annals of clinical and translational neurology. 9(6)
The long-term favorable safety profile of nusinersen provides an opportunity to consider a higher dose. We report on the relationships between nusinersen cerebrospinal fluid (CSF) exposure, biomarker levels, and clinical efficacy.The analyses used da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e6da626f90d7f37b47eff6eb548194
https://pubmed.ncbi.nlm.nih.gov/35567345
https://pubmed.ncbi.nlm.nih.gov/35567345
Autor:
María del Mar Garcia Romero, Gloria López Sobrino, Ramón Velázquez Fragua, José Manuel Caballero Caballero, Samuel Ignacio Pascual Pascual, Pilar Tirado Requero, César Rodríguez Sánchez
Publikováno v:
Toxicon. 190:S62-S63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dee640b86d7916163744fda49ee3c81
https://doi.org/10.1016/j.toxicon.2020.11.474
https://doi.org/10.1016/j.toxicon.2020.11.474